| human | Q5 |
| P11496 | CiNii Research ID | 1420001326232721792 |
| P9776 | e-Rad researcher number | 50376448 |
| P7783 | J-GLOBAL ID | 201801018503499279 |
| P496 | ORCID iD | 0000-0002-3421-8273 |
| P5029 | Researchmap ID | yakushiji322 |
| P27 | country of citizenship | Japan | Q17 |
| P108 | employer | University of Tokyo | Q7842 |
| Jichi Medical University | Q6192089 | ||
| P101 | field of work | urology | Q105650 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q113100822 | 1000 INTRINSIC PEPTIDES MEDIATES ADIPOSE TISSUE-DERIVED STEM CELL-INDUCED RESTORATION OF ERECTILE FUNCTION IN DIABETES RATS |
| Q40548144 | 14-3-3sigma is down-regulated in human prostate cancer |
| Q39294958 | 14-3-3ζ, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival |
| Q38740257 | A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor |
| Q35093466 | A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma |
| Q52885644 | Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration. |
| Q38832284 | Accessibility to surgical robot technology and prostate-cancer patient behavior for prostatectomy |
| Q51181511 | Acute pericarditis as a result of unusual metastasis of the visceral pleura in a patient with testicular seminoma. |
| Q41993990 | Adenocarcinoma at Anastomotic Site of Ureterosigmoidostomy Potentially of Urothelial Origin Spreading to the Upper Urinary Tract |
| Q36520796 | Adenoma-carcinoma Sequence in the Bladder After Augmentation Cystoplasty |
| Q53676261 | Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer. |
| Q51013577 | Adrenomedullin and angiopoietin-1 additively restore erectile function in diabetic rats: comparison with the combination therapy of vascular endothelial growth factor and angiopoietin-1. |
| Q58542117 | Aggressive Cancer Behavior of Latent Gleason Pattern 5 in Prostatectomy Specimens |
| Q51569179 | Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. |
| Q37735619 | Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells |
| Q39156237 | Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer |
| Q91609141 | Androgen-responsive tripartite motif 36 enhances tumor-suppressive effect by regulating apoptosis-related pathway in prostate cancer |
| Q53026190 | Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score. |
| Q53136666 | Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International Index of Erectile Function-5 questionnaires. |
| Q49597086 | Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer |
| Q44494306 | Association of rs6983561 polymorphism at 8q24 with prostate cancer mortality in a Japanese population |
| Q36291489 | Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality? |
| Q48298615 | Biphasic decline in renal function after radical cystectomy with urinary diversion |
| Q53479081 | Botulinum toxin type A injection for refractory interstitial cystitis: A randomized comparative study and predictors of treatment response. |
| Q52312081 | COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer. |
| Q46042382 | Cancer-related pain and quality of life in prostate cancer patients: assessment using the Functional Assessment of Prostate Cancer Therapy |
| Q92037807 | Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer |
| Q40584883 | Cessation of long-term adjuvant androgen deprivation therapy after radical prostatectomy: is it feasible? |
| Q41331306 | Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction. |
| Q97557611 | Clinical outcomes in donors and recipients of kidney transplantations involving medically complex living donors |
| Q36804916 | Clinical significance of amyloid precursor protein in patients with testicular germ cell tumor |
| Q55269517 | Clinical significance of random bladder biopsy in primary T1 bladder cancer. |
| Q39448680 | Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer |
| Q33418868 | Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinoma |
| Q96121784 | Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy |
| Q43433022 | Comparisons of perioperative outcomes and costs between open and laparoscopic radical prostatectomy: a propensity-score matching analysis based on the Japanese Diagnosis Procedure Combination database |
| Q95557898 | Computed tomography for the management of exit-site and tunnel infections in peritoneal dialysis patients |
| Q44690266 | Computed tomography-guided percutaneous acetic acid injection therapy for functioning adrenocortical adenoma |
| Q48583509 | Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study |
| Q61213171 | Corrigendum: TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression. |
| Q53019297 | CtBP2 modulates the androgen receptor to promote prostate cancer progression. |
| Q92303630 | Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer |
| Q40141833 | Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancer |
| Q48162018 | Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis. |
| Q44521416 | Differential expression of estrogen-related receptors beta and gamma (ERRbeta and ERRgamma) and their clinical significance in human prostate cancer |
| Q47373198 | Direct influence of systemic desensitization by resiniferatoxin on the activities of Aδ- and C-fibers in the rat primary bladder mechanosensitive afferent nerves |
| Q43647341 | Distant metastasis of renal cell carcinoma with a diameter of 3 cm or less-which is aggressive cancer? |
| Q51050274 | Docetaxel as a vital option for corticosteroid-refractory prostate cancer. |
| Q44654660 | Does mechanical bowel preparation improve quality of laparoscopic nephrectomy? Propensity score-matched analysis in Japanese series |
| Q47820506 | Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF. |
| Q39912689 | EBAG9 is a tumor-promoting and prognostic factor for bladder cancer |
| Q34211979 | EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer |
| Q87914949 | EXCISION OF GIANT PELVIC LIPOSARCOMA NECESSITATING FEMORAL-FEMORAL ARTERY BYPASS AND GAUZE PACKING FOR ILIAC ARTERY INVOLVEMENT AND MASSIVE PRE-SACRAL BLEEDING-A CASE REPORT |
| Q86759192 | Editorial comment to "Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin" |
| Q47880221 | Effects of Sildenafil, a Phosphodiesterase Type 5 Inhibitor, on the Primary Single Afferent Activity of the Rat Bladder |
| Q48293327 | Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study |
| Q36434014 | Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway |
| Q47717137 | Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine |
| Q51829383 | Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer. |
| Q39559634 | Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5. |
| Q39649549 | Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer |
| Q35199908 | Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer |
| Q45980137 | Expression of cytochrome P450 3A4 and its clinical significance in human prostate cancer. |
| Q48282286 | Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients |
| Q63966630 | Factors affecting choice between ureterostomy, ileal conduit and continent reservoir after radical cystectomy: Japanese series |
| Q39719926 | Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor |
| Q42481823 | Functional roles of bladder α1-adrenoceptors in the activation of single-unit primary bladder afferent activity in rats |
| Q34265694 | Granulocyte macrophage colony-stimulating factor as a predictor of the response of metastatic renal cell carcinoma to tyrosine kinase inhibitor therapy |
| Q40492381 | Hemiresective reconstruction of a redundant ileal conduit with severe bilateral ileal conduit-ureteral re fl ux. |
| Q90823772 | Hospital-Volume Effects on Perioperative Outcomes in Peritoneal Dialysis Catheter Implantation: Analysis of 2,505 Cases |
| Q50439588 | Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: Long-term outcomes and prognostic predictors |
| Q97681497 | Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors |
| Q53118153 | Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer. |
| Q44522411 | Impact of surgical intervention timing on the case fatality rate for Fournier's gangrene: an analysis of 379 cases |
| Q47642125 | Improvement of symptoms of aging in males by a preparation LEOPIN ROYAL containing aged garlic extract and other five of natural medicines - comparison with traditional herbal medicines (Kampo). |
| Q40288904 | Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy |
| Q52884935 | Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate Cancer. |
| Q40172120 | Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancer |
| Q87973947 | Inhibitory effects of silodosin on the bladder mechanosensitive afferent activities and their relation with bladder myogenic contractions in male rats with bladder outlet obstruction |
| Q33631876 | Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer |
| Q35180071 | Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer |
| Q43084529 | Intrascrotal dedifferentiated leiomyosarcoma originating from dartos muscle. |
| Q34781945 | Is mechanical bowel preparation in laparoscopic radical prostatectomy beneficial? An analysis of a Japanese national database |
| Q100476007 | Lacking transient receptor potential melastatin 2 attenuates lipopolysaccharide-induced bladder inflammation and its associated hypersensitivity in mice |
| Q84111971 | Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel |
| Q87434664 | Linguistic validation of the English version of the Core Lower Urinary Tract Symptom Score |
| Q87033942 | Linguistic validation of the English version of the Overactive Bladder Symptom Score |
| Q41911247 | Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer |
| Q51249760 | Longer operative time is associated with higher risk of severe complications after percutaneous nephrolithotomy: analysis of 1511 cases from a Japanese nationwide database. |
| Q93157344 | Longitudinal change of comprehensive lower urinary tract symptoms and various types of urinary incontinence during robot-assisted radical prostatectomy |
| Q53330187 | Lower ureteral lesion is an independent predictor of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. |
| Q79953554 | Lymphoepithelioma-like carcinoma of the renal pelvis |
| Q58097945 | May perioperative ultrasound-guided pelvic floor muscle training promote early recovery of urinary continence after robot-assisted radical prostatectomy? |
| Q51555118 | Measuring Contact Pressure of Lower Extremities in Patients Undergoing Robot-Assisted Radical Prostatectomy. |
| Q37096206 | Metachronous testicular tumor developing eight years after retroperitoneal extragonadal germ cell tumor |
| Q53519742 | Midurethral autologous fascial sling surgery with reconstruction of the lower abdominal wall using the tensor fascia lata muscle flap for post-hemipelvectomy stress urinary incontinence. |
| Q92327999 | Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies |
| Q34325767 | Multiple primary malignant neoplasms of the glottis, renal pelvis, urinary bladder, oral floor, prostate, and esophagus in a Japanese male patient: a case report |
| Q41512156 | Nocturia in men is a chaotic condition dominated by nocturnal polyuria |
| Q39006998 | Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder. |
| Q34720933 | Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer |
| Q39579080 | Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer |
| Q80080027 | Oncofetal protein glypican-3 in testicular germ-cell tumor |
| Q50203162 | Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate? |
| Q53696755 | Oncological and peri-surgical outcomes of radical prostatectomy for non-metastatic prostate cancer with prostate-specific antigen level of 50 ng/ml or greater. |
| Q37140357 | Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial? |
| Q48621346 | Overactive bladder is a negative predictor of achieving continence after robot-assisted radical prostatectomy |
| Q51797515 | Periurethral injection of sustained release basic fibroblast growth factor improves sphincteric contractility of the rat urethra denervated by botulinum-a toxin. |
| Q100497034 | Predictive factors and management of urinary tract infections after kidney transplantation: a retrospective cohort study |
| Q48140879 | Predictors of Early Continence after Robot-assisted Radical Prostatectomy. |
| Q47594245 | Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. |
| Q36961767 | Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT. |
| Q41027611 | Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study |
| Q40323637 | Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy |
| Q53961114 | Preventive Effects of Long-Term Caloric Restriction on Aging Related In Vivo Bladder Dysfunction and Molecular Biological Changes in the Bladder and Dorsal Root Ganglia in Rats. |
| Q44043932 | Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? |
| Q88916912 | Prognostic significance of neutrophil-to-lymphocyte ratio in collecting duct carcinoma |
| Q39765407 | Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder |
| Q36198184 | Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor |
| Q53089863 | Psychometric validation of the English version of the overactive bladder symptom score. |
| Q38969070 | Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth |
| Q94481840 | Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model |
| Q100536870 | Questionnaire survey assessing seasonal changes in lower urinary tract symptoms in men with benign prostate hyperplasia |
| Q38925687 | RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer |
| Q28550520 | Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality |
| Q39163721 | Reduction of prostate cancer incidence by naftopidil, an α1 -adrenoceptor antagonist and transforming growth factor-β signaling inhibitor |
| Q58557761 | Regional clinical practice variation in urology: Usage example of the Open Data of the National Database of Health Insurance Claims and Specific Health Checkups of Japan |
| Q39510824 | Regional, institutional and individual factors affecting selection of minimally invasive nephroureterectomy in Japan: a national database analysis |
| Q53639600 | Risk factors for clinical metastasis in men undergoing radical prostatectomy and immediate adjuvant androgen deprivation therapy. |
| Q33410167 | Risk factors for septic shock in acute obstructive pyelonephritis requiring emergency drainage of the upper urinary tract |
| Q95261362 | Robot-assisted partial nephrectomy of initial cases using a 3D square-block type kidney model |
| Q32177636 | Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy |
| Q92602016 | Robot-assisted radical prostatectomy versus volumetric modulated arc therapy: Comparison of front-line therapies for localized prostate cancer |
| Q35713472 | Robot-assisted versus other types of radical prostatectomy: population-based safety and cost comparison in Japan, 2012-2013 |
| Q41420813 | Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma. |
| Q51113460 | Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat. |
| Q39829620 | Sleep Apnea and Circadian Extracellular Fluid Change as Independent Factors for Nocturnal Polyuria |
| Q43047911 | Successful treatment of metastatic malignant fibrous histiocytoma of the kidney |
| Q91006649 | Sunitinib versus sorafenib for patients with advanced renal cell carcinoma with renal impairment before the immune-oncology therapy era |
| Q36524254 | Symptoms at diagnosis as independent prognostic factors in retroperitoneal liposarcoma |
| Q52882419 | Synergic Suppressive Effect of Silodosin and Imidafenacin on Non-Voiding Bladder Contractions in Male Rats with Subacute Bladder Outlet Obstruction. |
| Q33636574 | TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer |
| Q38832692 | TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression |
| Q48146777 | TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer |
| Q92293632 | TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma |
| Q64124920 | Tension-free vaginal mesh surgery versus laparoscopic sacrocolpopexy for pelvic organ prolapse: Analysis of perioperative outcomes using a Japanese national inpatient database |
| Q90030573 | The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma |
| Q35829785 | Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial |
| Q98206386 | Transient acute kidney injury observed immediately after robot-assisted radical prostatectomy but not after open radical prostatectomy |
| Q51147334 | Tubulovillous adenoma developing after urinary reconstruction using ileal segments. |
| Q40215965 | Twelve Months Follow-up of Injection of OnabotulinumtoxinA into Vesical Submucosa for Refractory Non-neurogenic Overactive Bladder |
| Q51003882 | URB937, a peripherally restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibres in rats. |
| Q35342962 | Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer |
| Q48179048 | Urinary bladder urothelial carcinoma with concurrent plasmacytoid and micropapillary differentiations: A report of two cases with an emphasis on serum carbohydrate antigen 19-9. |
| Q48527343 | Validation of an educational program balancing surgeon training and surgical quality control during robot-assisted radical prostatectomy |
| Q41620841 | Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world |
| Q85602401 | Video-urodynamic effects of mirabegron, a β3 -adrenoceptor agonist, in patients with low-compliance bladder |
| Q82305390 | WITHDRAWN: Relationships between 8q24 and 17q risk loci and sporadic or latent prostate cancer and the impacts of these loci on the clinicopathologic characteristics of prostate cancer |
| Q42678066 | Wide range and variation in minimally invasive surgery for renal malignancy in Japan: a population-based analysis |
| Q86288278 | Zoledronic acid administration in aggressive castration- resistant prostate cancer |
| Q85941250 | [A case of renal carcinoid with local recurrence and multiple lymph node metastases 4 years after partial nephrectomy] |
| Q80757203 | [Bladder recurrence of renal cell carcinoma: report of two cases] |
| Q84086280 | [Eight-year postsurgery recurrence of malignant fibrous histiocytoma of the left spermatic cord] |
| Q84774809 | [Predictors of operative blood loss in patients undergoing small incision radical prostatectomy] |
Search more.